Tips for cancer

Health Policy from JAMA Health Forum New Online https://ift.tt/Gemc284

This cohort study examines launch and postlaunch price developments of new cancer drugs in the US, Germany, and Switzerland. from JAMA Health Forum New Online https://ift.tt/Vp1OwMa

This Viewpoint discusses how prerequisite comprehensive lifestyle interventions for novel antiobesity medications may disproportionately impact patients at highest risk of obesity-related complications and perpetuate disparities in care. from JAMA Internal Medicine Online First https://ift.tt/TpAJz2r

This cross-sectional study examines the consequences of transitions from Medicaid to Medicare on coverage and use of dental services. from JAMA Health Forum New Online https://ift.tt/ieJmUkX

This Viewpoint discusses the Centers for Medicare & Medicaid Services Transitional Coverage for Emerging Technologies pathway. from JAMA Health Forum New Online https://ift.tt/apqTQrm

This JAMA Forum discusses ideas for saving money in health care such as reducing the need for care, reducing excessive prices, and shifting to lower-cost practices. from JAMA Health Forum New Online https://ift.tt/dq7Dr4N

This Viewpoint discusses the growing body of evidence that indicates that mifepristone and misoprostol meet the US Food and Drug Administration’s criteria for over-the-counter sale. from JAMA Internal Medicine Online First https://ift.tt/hXfJoU2

This cross-sectional study characterizes Medicare transitional pass-through payment approval rates and the premarket evidence used by US Food and Drug Administration to support authorization of new outpatient medical devices. from JAMA Health Forum New Online https://ift.tt/12qFXWw

This economic evaluation illustrates a manufacturer’s estimated spending and revenues as it discontinued a branded product and introduced a generic replacement in response to a policy change. from JAMA Health Forum New Online https://ift.tt/yJRStT2

This difference-in-differences study estimates whether state-level repeal of Section 14(c) of the Fair Labor Standards Act was associated with employment-related outcomes for people with cognitive disability. from JAMA Health Forum New Online https://ift.tt/Y1mE5bM

This Viewpoint describes the Centers for Medicare & Medicaid Services States Advancing All-Payer Health Equity Approaches and Development (AHEAD) model for academic medical centers. from JAMA Health Forum New Online https://ift.tt/3v4XSAV

This JAMA Forum discusses 4 focus areas developed by a collaborative of more than 40 organizations and experts in health care, social services, and other sectors designed to find ways to support and address social determinants of health with better program coordination and partnerships and novel financing approaches. from JAMA Health Forum New Online https://ift.tt/gLGlWCx

This Viewpoint describes the diffusion of direct-to-consumer wearable devices capable of early atrial fibrillation detection and the unclear implications for initiation of anticoagulation therapy based on such findings. from JAMA Internal Medicine Online First https://ift.tt/WSjqeou

This Viewpoint discusses the need to better understand potential risks associated with psychedelic and 3,4-methylenedioxymethamphetamine (MDMA) use to ensure safe and ethical practice and identifies 4 key research goals. from JAMA Health Forum New Online https://ift.tt/iqgMYcV

This JAMA Forum discusses the philosophy and ethics of population health, approaches that may improve the health of populations, ideas for improving decision-making for better health outcomes, and the partnerships needed to improve population health. from JAMA Health Forum New Online https://ift.tt/Gtsu3KF

In Reply We thank Björnsson for their Letter to the Editor about our study in JAMA Internal Medicine. Our study introduced innovative methods for improving the understanding of the risk for hepatotoxic effects associated with medications. We developed a systematic, reproducible approach that used electronic health record data to measure rates of hospitalization for severe acute liver injury (ALI) following medication initiation among patients without liver or biliary disease. We reduced the likelihood of capturing non–drug-related severe ALI by censoring as nonevents any patients with diagnoses of hepatobiliary disease, ischemic injury, alcoholic hepatitis, viral hepatitis, or other conditions that could precipitate ALI, encompassing more than 700 diagnoses from the International Classification of Diseases, Ninth and Tenth Revisions (ICD-9 and ICD-10) (included in eTables 2 and 3 in the supplementary materials of our article). We acknowledged that some severe ALI events might have been...

This cohort study examines the association between work requirements and safety-net program enrollment among Medicaid and Supplemental Nutrition Assistance Program (SNAP) enrollees in Connecticut. from JAMA Internal Medicine Online First https://ift.tt/dADEjGs

This Teachable Moment describes a 66-year-old woman with mild dysuria, vulvar discomfort, and recurrent urinary tract infections. from JAMA Internal Medicine Online First https://ift.tt/hZ2CArn

This Viewpoint describes the successes and areas for improvement of student-run clinics in the US. from JAMA Internal Medicine Online First https://ift.tt/PGWO6oD

This difference-in-differences analysis investigates changes in ownership of home health agencies in the US and associated changes in quality of care, patient volume, and staffing levels. from JAMA Health Forum New Online https://ift.tt/089Ndvc

This cross-setional study examines the feasibility of using march-in rights under the Bayh-Dole Act to systemically lower drug prices by removing patent barriers to competition using data from the Food and Drug Administration Orange Book from JAMA Health Forum New Online https://ift.tt/WVe57Ym

Health Policy from JAMA Health Forum New Online https://ift.tt/U9VTQ5M

This Viewpoint considers supply- instead of buy-side pressure to address the inflated cost of basic health services provided by hospitals. from JAMA Health Forum New Online https://ift.tt/ebA5oHS